BSE 623.50 NSE 622.80

Ms Christine Mundkur

Independent Director

Ms Christine Mundkur was appointed as independent director at Lupin, in April 2019. She is also a member of the director board for MannKind Corporation, USA, and was earlier associated with Impopharma Inc, Sandoz Inc and Barr Laboratories Inc. She has served as a strategic advisor to clients on generics, 505(b) 2, biosimilars, and NDA business strategies.

Mundkur graduated in chemistry and holds a doctor of jurisprudence degree from St Louis University.

Appointment Letter